New Joint Action to Reduce the Burden of Cardiovascular Disease and Diabetes

European CommissionNon-communicable diseases such as cardiovascular diseases and diabetes pose significant health challenges and are amongst the leading causes of mortality in the EU. A new Joint Action on CARdiovascular diseases and DIabetes in Europe (JACARDI), funded by the EU4Health programme with an unprecedented EUR 53 million, kicked off this week to support 21 countries to reduce the burden of these two non-communicable diseases (NCDs).

The initiative is set to deploy 142 pilot projects across Europe, covering the entire patient journey: from improving health literacy and awareness, enhancing screening and primary prevention among high-risk populations, reaching out to people living with cardiovascular diseases and diabetes as well as their care providers and improving service pathways, self-management and labour participation. JACARDI will also address transversal and intersectional aspects, e.g., promoting equity in health, social, cultural, and ethnic diversity, and the improvement of data availability.

Background information

Around two-thirds of premature deaths in the World Health Organization European Region – are caused by four major NCDs: cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. Behavioural and biological risk factors are at the root of 85% of this burden. With the Healthier Together – EU non-communicable diseases initiative, the Commission recognises the importance of a comprehensive, strategic approach to preventing NCDs.

Useful links:

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...